---
title: "Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma"
image: pheochromocytoma.png

members:
  - nils-gehlenborg
type: article
year: 2017
publisher: "https://linkinghub.elsevier.com/retrieve/pii/S1535610817300016"
doi: "10.1016/j.ccell.2017.01.001"
zotero-key: "Q8RWE79F"
cite:
  authors: "L Fishbein, I Leshchiner, V Walter, L Danilova, AG Robertson, AR Johnson, TM Lichtenberg, BA Murray, HK Ghayee, T Else, S Ling, SR Jefferys, AA De Cubas, B Wenz, E Korpershoek, AL Amelio, L Makowski, WK Rathmell, AP Gimenez-Roqueplo, TJ Giordano, SL Asa, AS Tischler, K Pacak, KL Nathanson, MD Wilkerson, R Akbani, A Ally, L Amar, AL Amelio, H Arachchi, SL Asa, RJ Auchus, JT Auman, R Baertsch, M Balasundaram, S Balu, DK Bartsch, E Baudin, T Bauer, A Beaver, C Benz, R Beroukhim, F Beuschlein, T Bodenheimer, L Boice, J Bowen, R Bowlby, D Brooks, R Carlsen, S Carter, CA Cassol, AD Cherniack, L Chin, J Cho, E Chuah, S Chudamani, L Cope, D Crain, E Curley, L Danilova, AA De Cubas, RR De Krijger, JA Demchok, T Deutschbein, N Dhalla, D Dimmock, WNM Dinjens, T Else, C Eng, J Eschbacher, M Fassnacht, I Felau, M Feldman, ML Ferguson, I Fiddes, L Fishbein, S Frazer, SB Gabriel, J Gardner, JM Gastier-Foster, N Gehlenborg, M Gerken, G Getz, J Geurts, HK Ghayee, AP Gimenez-Roqueplo, TJ Giordano, M Goldman, K Graim, M Gupta, D Haan, S Hahner, C Hantel, D Haussler, DN Hayes, DI Heiman, KA Hoadley, RA Holt, AP Hoyle, M Huang, B Hunt, CM Hutter, SR Jefferys, AR Johnson, SJM Jones, CD Jones, K Kasaian, E Kebebew, J Kim, P Kimes, T Knijnenburg, E Korpershoek, E Lander, MS Lawrence, R Lechan, D Lee, KM Leraas, A Lerario, I Leshchiner, TM Lichtenberg, P Lin, S Ling, J Liu, VA LiVolsi, L Lolla, Y Lotan, Y Lu, Y Ma, N Maison, L Makowski, D Mallery, M Mannelli, J Marquard, MA Marra, T Matthew, M Mayo, T Méatchi, S Meng, MJ Merino, O Mete, M Meyerson, PA Mieczkowski, GB Mills, RA Moore, O Morozova, S Morris, LE Mose, AJ Mungall, BA Murray, R Naresh, KL Nathanson, Y Newton, S Ng, Y Ni, MS Noble, F Nwariaku, K Pacak, JS Parker, E Paul, R Penny, CM Perou, AH Perou, T Pihl, J Powers, J Rabaglia, A Radenbaugh, NC Ramirez, A Rao, WK Rathmell, A Riester, J Roach, AG Robertson, S Sadeghi, G Saksena, S Salama, C Saller, G Sandusky, S Sbiera, JE Schein, SE Schumacher, C Shelton, T Shelton, M Sheth, Y Shi, J Shih, I Shmulevich, JV Simons, P Sipahimalani, T Skelly, HJ Sofia, A Sokolov, MG Soloway, C Sougnez, J Stuart, C Sun, T Swatloski, A Tam, D Tan, R Tarnuzzer, K Tarvin, N Thiessen, LB Thorne, HJ Timmers, AS Tischler, K Tse, V Uzunangelov, A Van Berkel, U Veluvolu, A Vicha, D Voet, J Waldmann, V Walter, Y Wan, Z Wang, TS Wang, J Weaver, JN Weinstein, D Weismann, B Wenz, MD Wilkerson, L Wise, T Wong, C Wong, Y Wu, L Yang, T Zelinka, JC Zenklusen, JJ Zhang, W Zhang, J Zhu, F Zinzindohoué, E Zmuda"
  published: "*Cancer Cell* **31**(2):181-193"
---
We report a comprehensive molecular characterization of pheochromocytomas and paragangliomas (PCCs/PGLs), a rare tumor type. Multi-platform integration revealed that PCCs/PGLs are driven by diverse alterations affecting multiple genes and pathways. Pathogenic germline mutations occurred in eight PCC/PGL susceptibility genes. We identified CSDE1 as a somatically mutated driver gene, complementing four known drivers (HRAS, RET, EPAS1, and NF1). We also discovered fusion genes in PCCs/PGLs, involving MAML3, BRAF, NGFR, and NF1. Integrated analysis classified PCCs/PGLs into four molecularly defined groups: a kinase signaling subtype, a pseudohypoxia subtype, a Wnt-altered subtype, driven by MAML3 and CSDE1, and a cortical admixture subtype. Correlates of metastatic PCCs/PGLs included the MAML3 fusion gene. This integrated molecular characterization provides a comprehensive foundation for developing PCC/PGL precision medicine.